New developments in ablation therapy for hepatocellular carcinoma:combination with systemic therapy and radiotherapy  

作　　者：Kauzshi Numata Feiqian Wang 

机构地区：[1]Gastroenterological Center,Yokohama City University Medical Center,Yokohama,Japan [2]Ultrasound Department,The First Affiliated Hospital of Xi’an Jiaotong University,Xi’an,China

出　　处：《Hepatobiliary Surgery and Nutrition》2022年第5期766-769,共4页肝胆外科与营养（英文）

基　　金：supported by the National Natural Science Foundation of China(No.82102074)Key Science and Technology Program of Shaanxi Province of China(No.2022SF-320).

摘　　要：We carefully read the review article,which compared three types of ablation therapies such as radiofrequency ablation(RFA),high-intensity focused ultrasound(HIFU),and microwave ablation(MWA)for Barcelona clinic liver cancer(BCLC)stage 0 and A(early-stage)hepatocellular carcinoma(HCC)patients with cirrhosis by Cheung et al.(1)published in 2021 in Hepatobiliary Surgery and Nutrition.This manuscript well described the principles,indications,and limitations of these ablation systems in detail(1).We would like to provide several comments.

关 键 词：SURGERY HEPATOCELLULAR al. 

分 类 号：R735.7[医药卫生—肿瘤]